1019022-33-3

Basic information

• Product Name: IMidazo[1,2-a]pyridine-3-carboxylic acid, 7-chloro-
• Synonyms: IMidazo[1,2-a]pyridine-3-carboxylic acid, 7-chloro-;7-Chloro-imidazo[1,2-a]pyridine-3-carboxylic acid
• CAS NO: 1019022-33-3
• Molecular Formula: C8H5ClN2O2
• Molecular Weight: 196.5905
• Mol File: 1019022-33-3.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: IMidazo[1,2-a]pyridine-3-carboxylic acid, 7-chloro-(CAS DataBase Reference)
• NIST Chemistry Reference: IMidazo[1,2-a]pyridine-3-carboxylic acid, 7-chloro-(1019022-33-3)
• EPA Substance Registry System: IMidazo[1,2-a]pyridine-3-carboxylic acid, 7-chloro-(1019022-33-3)

Safety Data

• Hazardous Substances Data: 1019022-33-3(Hazardous Substances Data)

Upstream product

• 1296201-68-7 7-chloro-imidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester 
• 1072-98-6 5-chloro-2-pyridylamine 

Relevant articles and documents

BICYCLIC HETEROARYLS AS KINASE INHIBITORS

The invention is directed to heteroaryl compounds useful as inhibitors of various kinase enzymes. In various embodiments, the invention provides a heteroaryl compound having inhibitory bioactivity with respect to a Rho kinase, an AKT kinase, a p70S6K kinase, a LIM kinase, an IKK kinase, a Flt kinase, an Aurora kinase, or a Src kinase, or any combination thereof. Compounds of the invention include bicyclic heteroaryl compounds of formula (I), which can contain a bridging nitrogen atom at a ring junction. The invention further provides methods of synthesis of compounds of the invention, pharmaceutical compositions, pharmaceutical combinations, and methods of treatment of malconditions using compounds of the invention.